MARKET

SGP

SGP

SpyGlass Pharma, Inc.
NASDAQ
21.18
+2.37
+12.60%
After Hours: 21.15 -0.03 -0.14% 16:53 06/26 EDT
OPEN
18.98
PREV CLOSE
18.81
HIGH
21.31
LOW
18.94
VOLUME
1.48M
TURNOVER
--
52 WEEK HIGH
32.44
52 WEEK LOW
17.06
MARKET CAP
708.12M
P/E (TTM)
-30.5451
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SGP last week (0615-0619)?
Weekly Report · 6d ago
SPYGLASS PHARMA APPOINTS SHANNON TREVIÑO AS GENERAL COUNSEL
Reuters · 06/15 12:00
Weekly Report: what happened at SGP last week (0608-0612)?
Weekly Report · 06/15 10:46
Weekly Report: what happened at SGP last week (0601-0605)?
Weekly Report · 06/08 10:40
SpyGlass Pharma names Mike Pinder vice president, marketing
PUBT · 06/02 12:08
SPYGLASS PHARMA APPOINTS MIKE PINDER AS VICE PRESIDENT, MARKETING
Reuters · 06/02 12:00
Weekly Report: what happened at SGP last week (0525-0529)?
Weekly Report · 06/01 10:47
Analysts Offer Insights on NA Companies: SpyGlass Pharma (SGP) and Fiserv (FISV)
TipRanks · 05/29 11:40
More
About SGP
SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.

Webull offers SpyGlass Pharma, Inc. stock information, including NASDAQ: SGP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGP stock methods without spending real money on the virtual paper trading platform.